Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Fortress Biotech, Inc. (FBIO)

Fortress Biotech repays remaining $15.0 million under Oaktree credit facility in full

Neutral Impact 2 of 5 financing Written later

Fortress Biotech repaid in full the remaining $15.0 million of principal on its Oaktree senior secured credit facility on September 30, 2026, plus about $435,000 of accrued interest, a $150,000 prepayment fee and other closing costs. With the repayment, the debt is satisfied, liens on company property are released, and the Oaktree Agreement terminated automatically.

Key points

  • Principal repaid: $15.0 million on September 30, 2026, with the facility originally a $50.0 million senior secured credit agreement dated July 25, 2024
  • Additional payments: about $435,000 in accrued interest and a $150,000 prepayment fee, plus other closing costs
  • Upon repayment, all liens securing the facility were released and the Oaktree Agreement terminated

The filing

CompanyFortress Biotech, Inc. (FBIO)
Form8-K, current report
Filed with the SECOct 1, 2026, 4:30 PM ET
Accession number0001104659-26-112845

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 01, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.